RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+12%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.07B
AUM Growth
+$3.07B
(-7.2%)
Cap. Flow
-$383M
Cap. Flow
% of AUM
-12.45%
Top 10 Holdings %
Top 10 Hldgs %
34.44%
Holding
116
New
6
Increased
34
Reduced
30
Closed
6
Top Buys
| 1 |
Summit Therapeutics
SMMT
|
$22.8M |
| 2 |
Eli Lilly
LLY
|
$18.2M |
| 3 |
Nuvalent
NUVL
|
$17.8M |
| 4 |
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
|
$14.9M |
| 5 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$11.4M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$156M |
| 2 |
Idexx Laboratories
IDXX
|
$58.2M |
| 3 |
Evolent Health
EVH
|
$56.8M |
| 4 |
Boston Scientific
BSX
|
$30M |
| 5 |
Acadia Healthcare
ACHC
|
$23M |
Sector Composition
| 1 | Healthcare | 97.81% |
| 2 | Consumer Staples | 1.99% |
| 3 | Industrials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Revolution Medicines
RVMD
$7.43B
| $45.8M | 1.49% |
1,009,945
+66,750
| +7% | +$3.03M |
|
27
Merus
MRUS
$5.04B
| $44.6M | 1.45% |
892,549
-108,524
| -11% | -$5.42M |
|
|
28
Nuvalent
NUVL
$5.74B
| $44M | 1.43% |
429,994
+174,005
| +68% | +$17.8M |
|
|
MREO
29
Mereo BioPharma
MREO
$275M
| $39.2M | 1.27% |
9,534,170
+250,678
| +3% | +$1.03M |
|
|
30
Boston Scientific
BSX
$159B
| $38.5M | 1.25% |
460,000
-357,500
| -44% | -$30M |
|
31
Sarepta Therapeutics
SRPT
$1.98B
| $38.4M | 1.25% |
307,500
+23,500
| +8% | +$2.93M |
|
32
Edwards Lifesciences
EW
$47.7B
| $38.1M | 1.24% |
576,900
+26,900
| +5% | +$1.78M |
|
33
Celldex Therapeutics
CLDX
$1.57B
| $37.5M | 1.22% |
1,103,778
-295,216
| -21% | -$10M |
|
34
Agilon Health
AGL
$497M
| $35.8M | 1.16% |
9,096,800
+196,800
| +2% | +$773K |
|
35
DexCom
DXCM
$30.9B
| $35.1M | 1.14% |
524,000
+24,000
| +5% | +$1.61M |
|
36
Immunovant
IMVT
$2.91B
| $34.8M | 1.13% |
1,221,309
+35,655
| +3% | +$1.02M |
|
37
Zai Lab
ZLAB
$3.48B
| $31.8M | 1.03% |
1,315,673
+17,800
| +1% | +$430K |
|
38
Insulet
PODD
$24.2B
| $31.2M | 1.01% |
134,000
-61,000
| -31% | -$14.2M |
|
39
Agios Pharmaceuticals
AGIO
$2.36B
| $31.1M | 1.01% |
699,389
-344,872
| -33% | -$15.3M |
|
40
iRhythm Technologies
IRTC
$5.67B
| $29.5M | 0.96% |
397,500
| – | – |
|
41
Align Technology
ALGN
$9.59B
| $29.1M | 0.95% |
114,500
-13,000
| -10% | -$3.31M |
|
42
BioCryst Pharmaceuticals
BCRX
$1.74B
| $27.5M | 0.9% |
3,622,358
+3,100
| +0.1% | +$23.6K |
|
43
Inspire Medical Systems
INSP
$2.53B
| $27.4M | 0.89% |
130,000
| – | – |
|
44
Akero Therapeutics
AKRO
$3.65B
| $26.8M | 0.87% |
933,399
-140,862
| -13% | -$4.04M |
|
45
Azenta
AZTA
$1.35B
| $25.8M | 0.84% |
532,500
-163,500
| -23% | -$7.92M |
|
46
Legend Biotech
LEGN
$6.64B
| $24.8M | 0.81% |
508,932
+3,146
| +0.6% | +$153K |
|
47
Warby Parker
WRBY
$3.08B
| $23.5M | 0.76% |
1,439,050
-640,950
| -31% | -$10.5M |
|
|
48
Summit Therapeutics
SMMT
$17.5B
| $22.8M | 0.74% |
+1,040,000
| New | +$22.8M |
|
49
Lifestance Health
LFST
$2.14B
| $21.7M | 0.71% |
3,101,000
-1,726,700
| -36% | -$12.1M |
|
50
Oscar Health
OSCR
$4.57B
| $21.5M | 0.7% |
1,011,400
-240,100
| -19% | -$5.09M |
|